European Commission clears Johnson and Johnson's acquisition of DePuy
This article was originally published in Clinica
Executive Summary
The European Commission has told Johnson & Johnson that it can buy orthopaedics company DePuy. A question mark was held over the deal last month when the Commission decided it needed further information before reaching a decision (see Clinica No 831, p 9).